Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Pentaborate Pentahydrate in Mild to Moderate Alzheimer’s Disease (Phase 1–2)
IRCT20220614055167N7Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sodium pentaborate pentahydrate in Alzheimer's disease (AD), sponsored by Tabriz University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on IRCT20220614055167N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220614055167N7.